Active Ingredient
Pseudoephedrine HCI, USP 120 mg
The following Structured Product Label (SPL) was submitted to the FDA by Strategic Sourcing Services Llc for the product Pseudoephedrine Hydrochloride (NDC 62011-0306). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, uses, do not use, ask a doctor before use if you have, when using this product, stop use and ask a doctor if, if pregnant or breast-feeding,, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Pseudoephedrine HCI, USP 120 mg
Nasal decongestant
temporarily relieves nasal congestion due to:
if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
castor oil, colloidal silicon dioxide, hypromellose, microcrystalline cellulose, magnesium stearate, titanium dioxide
NDC 62011-0306-1
Compare to Sudafed® 12 Hour active ingredient*
nasal decongestant
pseudoephedrine hydrochloride 120 mg extended-release tablets, USP
long-acting nasal decongestant
nasal & sinus congestion due to colds & allergies/sinus pressure
12 Hour non-drowsy maximum strength
10 coated capsule-shaped tablets 120 mg each
* Please review the disclaimer below.